Neurometabolic Disorders and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neurometabolic Disorders Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurometabolic Disorders Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurometabolic Disorders Overall Market Size
2.1 Global Neurometabolic Disorders Market Size: 2023 VS 2030
2.2 Global Neurometabolic Disorders Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neurometabolic Disorders Players in Global Market
3.2 Top Global Neurometabolic Disorders Companies Ranked by Revenue
3.3 Global Neurometabolic Disorders Revenue by Companies
3.4 Top 3 and Top 5 Neurometabolic Disorders Companies in Global Market, by Revenue in 2023
3.5 Global Companies Neurometabolic Disorders Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neurometabolic Disorders Players in Global Market
3.6.1 List of Global Tier 1 Neurometabolic Disorders Companies
3.6.2 List of Global Tier 2 and Tier 3 Neurometabolic Disorders Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurometabolic Disorders Market Size Markets, 2023 & 2030
4.1.2 Gaucher?s Disease
4.1.3 Fabry Disease
4.1.4 Pompe Disease
4.1.5 Mucopolysaccharidosis VI
4.1.6 Other
4.2 By Type - Global Neurometabolic Disorders Revenue & Forecasts
4.2.1 By Type - Global Neurometabolic Disorders Revenue, 2019-2024
4.2.2 By Type - Global Neurometabolic Disorders Revenue, 2025-2030
4.2.3 By Type - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurometabolic Disorders Market Size, 2023 & 2030
5.1.2 Oral
5.1.3 Parenteral
5.2 By Application - Global Neurometabolic Disorders Revenue & Forecasts
5.2.1 By Application - Global Neurometabolic Disorders Revenue, 2019-2024
5.2.2 By Application - Global Neurometabolic Disorders Revenue, 2025-2030
5.2.3 By Application - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Neurometabolic Disorders Market Size, 2023 & 2030
6.2 By Region - Global Neurometabolic Disorders Revenue & Forecasts
6.2.1 By Region - Global Neurometabolic Disorders Revenue, 2019-2024
6.2.2 By Region - Global Neurometabolic Disorders Revenue, 2025-2030
6.2.3 By Region - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Neurometabolic Disorders Revenue, 2019-2030
6.3.2 US Neurometabolic Disorders Market Size, 2019-2030
6.3.3 Canada Neurometabolic Disorders Market Size, 2019-2030
6.3.4 Mexico Neurometabolic Disorders Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Neurometabolic Disorders Revenue, 2019-2030
6.4.2 Germany Neurometabolic Disorders Market Size, 2019-2030
6.4.3 France Neurometabolic Disorders Market Size, 2019-2030
6.4.4 U.K. Neurometabolic Disorders Market Size, 2019-2030
6.4.5 Italy Neurometabolic Disorders Market Size, 2019-2030
6.4.6 Russia Neurometabolic Disorders Market Size, 2019-2030
6.4.7 Nordic Countries Neurometabolic Disorders Market Size, 2019-2030
6.4.8 Benelux Neurometabolic Disorders Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Neurometabolic Disorders Revenue, 2019-2030
6.5.2 China Neurometabolic Disorders Market Size, 2019-2030
6.5.3 Japan Neurometabolic Disorders Market Size, 2019-2030
6.5.4 South Korea Neurometabolic Disorders Market Size, 2019-2030
6.5.5 Southeast Asia Neurometabolic Disorders Market Size, 2019-2030
6.5.6 India Neurometabolic Disorders Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Neurometabolic Disorders Revenue, 2019-2030
6.6.2 Brazil Neurometabolic Disorders Market Size, 2019-2030
6.6.3 Argentina Neurometabolic Disorders Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neurometabolic Disorders Revenue, 2019-2030
6.7.2 Turkey Neurometabolic Disorders Market Size, 2019-2030
6.7.3 Israel Neurometabolic Disorders Market Size, 2019-2030
6.7.4 Saudi Arabia Neurometabolic Disorders Market Size, 2019-2030
6.7.5 UAE Neurometabolic Disorders Market Size, 2019-2030
7 Neurometabolic Disorders Companies Profiles
7.1 Amicus Therapeutics
7.1.1 Amicus Therapeutics Company Summary
7.1.2 Amicus Therapeutics Business Overview
7.1.3 Amicus Therapeutics Neurometabolic Disorders Major Product Offerings
7.1.4 Amicus Therapeutics Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.1.5 Amicus Therapeutics Key News & Latest Developments
7.2 ISU Abxis
7.2.1 ISU Abxis Company Summary
7.2.2 ISU Abxis Business Overview
7.2.3 ISU Abxis Neurometabolic Disorders Major Product Offerings
7.2.4 ISU Abxis Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.2.5 ISU Abxis Key News & Latest Developments
7.3 JCR Pharmaceuticals
7.3.1 JCR Pharmaceuticals Company Summary
7.3.2 JCR Pharmaceuticals Business Overview
7.3.3 JCR Pharmaceuticals Neurometabolic Disorders Major Product Offerings
7.3.4 JCR Pharmaceuticals Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.3.5 JCR Pharmaceuticals Key News & Latest Developments
7.4 Biosidus
7.4.1 Biosidus Company Summary
7.4.2 Biosidus Business Overview
7.4.3 Biosidus Neurometabolic Disorders Major Product Offerings
7.4.4 Biosidus Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.4.5 Biosidus Key News & Latest Developments
7.5 Greenovation Biotech
7.5.1 Greenovation Biotech Company Summary
7.5.2 Greenovation Biotech Business Overview
7.5.3 Greenovation Biotech Neurometabolic Disorders Major Product Offerings
7.5.4 Greenovation Biotech Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.5.5 Greenovation Biotech Key News & Latest Developments
7.6 UAB Proforma
7.6.1 UAB Proforma Company Summary
7.6.2 UAB Proforma Business Overview
7.6.3 UAB Proforma Neurometabolic Disorders Major Product Offerings
7.6.4 UAB Proforma Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.6.5 UAB Proforma Key News & Latest Developments
7.7 Dong-A Socio Group
7.7.1 Dong-A Socio Group Company Summary
7.7.2 Dong-A Socio Group Business Overview
7.7.3 Dong-A Socio Group Neurometabolic Disorders Major Product Offerings
7.7.4 Dong-A Socio Group Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.7.5 Dong-A Socio Group Key News & Latest Developments
7.8 ExSAR Corporation
7.8.1 ExSAR Corporation Company Summary
7.8.2 ExSAR Corporation Business Overview
7.8.3 ExSAR Corporation Neurometabolic Disorders Major Product Offerings
7.8.4 ExSAR Corporation Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.8.5 ExSAR Corporation Key News & Latest Developments
7.9 Lixte Biotechnology
7.9.1 Lixte Biotechnology Company Summary
7.9.2 Lixte Biotechnology Business Overview
7.9.3 Lixte Biotechnology Neurometabolic Disorders Major Product Offerings
7.9.4 Lixte Biotechnology Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.9.5 Lixte Biotechnology Key News & Latest Developments
7.10 Neuraltus Pharmaceuticals
7.10.1 Neuraltus Pharmaceuticals Company Summary
7.10.2 Neuraltus Pharmaceuticals Business Overview
7.10.3 Neuraltus Pharmaceuticals Neurometabolic Disorders Major Product Offerings
7.10.4 Neuraltus Pharmaceuticals Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.10.5 Neuraltus Pharmaceuticals Key News & Latest Developments
7.11 Protalix
7.11.1 Protalix Company Summary
7.11.2 Protalix Business Overview
7.11.3 Protalix Neurometabolic Disorders Major Product Offerings
7.11.4 Protalix Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.11.5 Protalix Key News & Latest Developments
7.12 Pharming Group
7.12.1 Pharming Group Company Summary
7.12.2 Pharming Group Business Overview
7.12.3 Pharming Group Neurometabolic Disorders Major Product Offerings
7.12.4 Pharming Group Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.12.5 Pharming Group Key News & Latest Developments
7.13 Protalix BioTherapeutics
7.13.1 Protalix BioTherapeutics Company Summary
7.13.2 Protalix BioTherapeutics Business Overview
7.13.3 Protalix BioTherapeutics Neurometabolic Disorders Major Product Offerings
7.13.4 Protalix BioTherapeutics Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.13.5 Protalix BioTherapeutics Key News & Latest Developments
7.14 Amicus
7.14.1 Amicus Company Summary
7.14.2 Amicus Business Overview
7.14.3 Amicus Neurometabolic Disorders Major Product Offerings
7.14.4 Amicus Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.14.5 Amicus Key News & Latest Developments
7.15 Biomarin
7.15.1 Biomarin Company Summary
7.15.2 Biomarin Business Overview
7.15.3 Biomarin Neurometabolic Disorders Major Product Offerings
7.15.4 Biomarin Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.15.5 Biomarin Key News & Latest Developments
7.16 Genzyme
7.16.1 Genzyme Company Summary
7.16.2 Genzyme Business Overview
7.16.3 Genzyme Neurometabolic Disorders Major Product Offerings
7.16.4 Genzyme Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.16.5 Genzyme Key News & Latest Developments
7.17 Shire
7.17.1 Shire Company Summary
7.17.2 Shire Business Overview
7.17.3 Shire Neurometabolic Disorders Major Product Offerings
7.17.4 Shire Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.17.5 Shire Key News & Latest Developments
7.18 Greencross
7.18.1 Greencross Company Summary
7.18.2 Greencross Business Overview
7.18.3 Greencross Neurometabolic Disorders Major Product Offerings
7.18.4 Greencross Neurometabolic Disorders Revenue in Global Market (2019-2024)
7.18.5 Greencross Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neurometabolic Disorders Market Opportunities & Trends in Global Market
Table 2. Neurometabolic Disorders Market Drivers in Global Market
Table 3. Neurometabolic Disorders Market Restraints in Global Market
Table 4. Key Players of Neurometabolic Disorders in Global Market
Table 5. Top Neurometabolic Disorders Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Neurometabolic Disorders Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Neurometabolic Disorders Revenue Share by Companies, 2019-2024
Table 8. Global Companies Neurometabolic Disorders Product Type
Table 9. List of Global Tier 1 Neurometabolic Disorders Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neurometabolic Disorders Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Neurometabolic Disorders Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Neurometabolic Disorders Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Neurometabolic Disorders Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Neurometabolic Disorders Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Neurometabolic Disorders Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Neurometabolic Disorders Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Neurometabolic Disorders Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Neurometabolic Disorders Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Neurometabolic Disorders Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Neurometabolic Disorders Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Neurometabolic Disorders Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Neurometabolic Disorders Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Neurometabolic Disorders Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Neurometabolic Disorders Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Neurometabolic Disorders Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Neurometabolic Disorders Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Neurometabolic Disorders Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Neurometabolic Disorders Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Neurometabolic Disorders Revenue, (US$, Mn), 2025-2030
Table 30. Amicus Therapeutics Company Summary
Table 31. Amicus Therapeutics Neurometabolic Disorders Product Offerings
Table 32. Amicus Therapeutics Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 33. Amicus Therapeutics Key News & Latest Developments
Table 34. ISU Abxis Company Summary
Table 35. ISU Abxis Neurometabolic Disorders Product Offerings
Table 36. ISU Abxis Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 37. ISU Abxis Key News & Latest Developments
Table 38. JCR Pharmaceuticals Company Summary
Table 39. JCR Pharmaceuticals Neurometabolic Disorders Product Offerings
Table 40. JCR Pharmaceuticals Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 41. JCR Pharmaceuticals Key News & Latest Developments
Table 42. Biosidus Company Summary
Table 43. Biosidus Neurometabolic Disorders Product Offerings
Table 44. Biosidus Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 45. Biosidus Key News & Latest Developments
Table 46. Greenovation Biotech Company Summary
Table 47. Greenovation Biotech Neurometabolic Disorders Product Offerings
Table 48. Greenovation Biotech Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 49. Greenovation Biotech Key News & Latest Developments
Table 50. UAB Proforma Company Summary
Table 51. UAB Proforma Neurometabolic Disorders Product Offerings
Table 52. UAB Proforma Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 53. UAB Proforma Key News & Latest Developments
Table 54. Dong-A Socio Group Company Summary
Table 55. Dong-A Socio Group Neurometabolic Disorders Product Offerings
Table 56. Dong-A Socio Group Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 57. Dong-A Socio Group Key News & Latest Developments
Table 58. ExSAR Corporation Company Summary
Table 59. ExSAR Corporation Neurometabolic Disorders Product Offerings
Table 60. ExSAR Corporation Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 61. ExSAR Corporation Key News & Latest Developments
Table 62. Lixte Biotechnology Company Summary
Table 63. Lixte Biotechnology Neurometabolic Disorders Product Offerings
Table 64. Lixte Biotechnology Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 65. Lixte Biotechnology Key News & Latest Developments
Table 66. Neuraltus Pharmaceuticals Company Summary
Table 67. Neuraltus Pharmaceuticals Neurometabolic Disorders Product Offerings
Table 68. Neuraltus Pharmaceuticals Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 69. Neuraltus Pharmaceuticals Key News & Latest Developments
Table 70. Protalix Company Summary
Table 71. Protalix Neurometabolic Disorders Product Offerings
Table 72. Protalix Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 73. Protalix Key News & Latest Developments
Table 74. Pharming Group Company Summary
Table 75. Pharming Group Neurometabolic Disorders Product Offerings
Table 76. Pharming Group Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 77. Pharming Group Key News & Latest Developments
Table 78. Protalix BioTherapeutics Company Summary
Table 79. Protalix BioTherapeutics Neurometabolic Disorders Product Offerings
Table 80. Protalix BioTherapeutics Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 81. Protalix BioTherapeutics Key News & Latest Developments
Table 82. Amicus Company Summary
Table 83. Amicus Neurometabolic Disorders Product Offerings
Table 84. Amicus Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 85. Amicus Key News & Latest Developments
Table 86. Biomarin Company Summary
Table 87. Biomarin Neurometabolic Disorders Product Offerings
Table 88. Biomarin Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 89. Biomarin Key News & Latest Developments
Table 90. Genzyme Company Summary
Table 91. Genzyme Neurometabolic Disorders Product Offerings
Table 92. Genzyme Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 93. Genzyme Key News & Latest Developments
Table 94. Shire Company Summary
Table 95. Shire Neurometabolic Disorders Product Offerings
Table 96. Shire Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 97. Shire Key News & Latest Developments
Table 98. Greencross Company Summary
Table 99. Greencross Neurometabolic Disorders Product Offerings
Table 100. Greencross Neurometabolic Disorders Revenue (US$, Mn) & (2019-2024)
Table 101. Greencross Key News & Latest Developments
List of Figures
Figure 1. Neurometabolic Disorders Segment by Type in 2023
Figure 2. Neurometabolic Disorders Segment by Application in 2023
Figure 3. Global Neurometabolic Disorders Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Neurometabolic Disorders Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Neurometabolic Disorders Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neurometabolic Disorders Revenue in 2023
Figure 8. By Type - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 9. By Application - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 10. By Type - Global Neurometabolic Disorders Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 12. By Application - Global Neurometabolic Disorders Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 14. By Region - Global Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 15. By Country - North America Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 16. US Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 20. Germany Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 21. France Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 28. China Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 32. India Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 34. Brazil Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Neurometabolic Disorders Revenue Market Share, 2019-2030
Figure 37. Turkey Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Neurometabolic Disorders Revenue, (US$, Mn), 2019-2030
Figure 41. Amicus Therapeutics Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. ISU Abxis Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. JCR Pharmaceuticals Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Biosidus Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Greenovation Biotech Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. UAB Proforma Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Dong-A Socio Group Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. ExSAR Corporation Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Lixte Biotechnology Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Neuraltus Pharmaceuticals Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Protalix Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Pharming Group Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Protalix BioTherapeutics Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Amicus Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Biomarin Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 56. Genzyme Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 57. Shire Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 58. Greencross Neurometabolic Disorders Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
